BioAge Labs Inc. (BIOA) vs Profound Medical Corp. (PROF)
A side-by-side comparison of BioAge Labs Inc. and Profound Medical Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIOA
BioAge Labs Inc.
$6.24HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
PROF
Profound Medical Corp.
$6.13HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
Total return — BIOA vs PROF
growth of $100 · dividends reinvested · last 2yBIOA -65.3% (-41.1%/yr)PROF -19.3% (-10.2%/yr)PROF compounded faster over this window
BIOA PROF
BIOA vs PROF: by the numbers
- •BIOA is the larger company ($235M vs $223M market cap).
- •Both run net losses; PROF's is the smaller (-171.72% vs -912.25% net margin).
Metrics side by side
Valuation
| Metric | BIOA | PROF |
|---|---|---|
| P/S ratio | 22.67 | 11.72 |
| P/B ratio | 0.63 | 4.47 |
Profitability
| Metric | BIOA | PROF |
|---|---|---|
| Gross margin | 99.39% | 71.79% |
| Operating margin | -1026.28% | -256.27% |
| Net margin | -912.25% | -171.72% |
| ROE | -25.20% | -65.59% |
| ROIC | -28.14% | -61.03% |
Growth (annualized)
| Metric | BIOA | PROF |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 16.55% |
| Total return CAGR (5Y) | N/A | -15.23% |
Go deeper
Dig into the metrics
BioAge Labs ROEProfound Medical ROEBioAge Labs operating marginProfound Medical operating marginBioAge Labs revenue growthProfound Medical revenue growthBioAge Labs free cash flowProfound Medical free cash flow
BioAge Labs & Profound Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.